ClinicalTrialsFinder

Early Hormone Receptor-positive (HR-positive) Clinical Trials in Paris

1 recruitingParis, France

Showing 1–1 of 1 trials

Recruiting

Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer

HER2-negative Breast CancerBreast Cancer (Early Breast Cancer)Breast Cancer Survivors+2 more
Assistance Publique - Hôpitaux de Paris1,000 enrolled1 locationNCT07379918